On December 06, 2023, the Eurasian Patent Office instituted a ground breaking stride in IP system by adopting the WIPO Standardisation termed- ST.91. This standardisation provides recommendations for Intellectual Property
Novo Nordisk’s Ozempic, also known as semaglutide, is a drug generally used to treat type-2 diabetes. However, the market for Ozempic is facing major shortages in supply globally due to